Business
Delhi HC Temporarily Restricts Supply Of Zydus Cancer Drug Ikra
The Delhi High Court has temporarily halted the supply of Zydus Lifesciences’ cancer drug Ikra amid a patent dispute with AbbVie. The decision is expected to affect patients awaiting the medication and could impact the pharmaceutical market. The court’s order is a key development in the ongoing legal battle.
Read news like this in 60 seconds
Short2News gives you the day's news as fast 60-word cards, in your own language.
- News in Telugu, Hindi, Tamil, Kannada and 12 languages
- Short summaries — verified facts, zero clickbait
- AI voice audio reading — listen hands-free
- Earn rewards as a verified local creator
More Top Stories
Five Stocks to Buy Today: Ather, Coal India, SBI Cards
Multibagger Apar Industries Delivers 2,540% In 5 Years, Outperforming Nifty 500
Citi Says HCLTech’s AI Revenue Lags Peers
EPFO: పీఎఫ్ అకౌంట్లో రూ.15 వేలు జారీ
Oil nears $100 as Iran attacks US targets in Jordan
Amid cost-saving drive, JLR to cut 4k jobs over 2 years